alexa Side Effect Profile Of Drugs Used In 100 Heart Transplant Patients-An Indian Study
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

36th Cardiovascular Nursing & Nurse Practitioners Meeting
July 10-11, 2017 Chicago, USA

R Ravi Kumar, K R Balakrishnan and K G Suresh Rao
Fortis Malar Hospital, India
Posters & Accepted Abstracts: J Clin Exp Cardiolog
DOI: 10.4172/2155-9880-C1-075
Abstract
Introduction: We studied 100 patients undergoing heart transplant in our center between 2011-2016, for the drug side effect profile and clinical course. Materials & Methods: Age range considered was 10-66 years. There were 74 males and 36 females. All patients were NYHA class 3 and above, 56 were in NYHA class 4 (Severe CHF) and 44 were in intermacs grade 3 and below. 12 were on preop ECMO support. PVR range was from 0.5 to 6.9 wood units (prior to injection milrinone or nitric oxide). Results & Analysis: Just before heart transplant, all patients received 10-20 mg of basiliximab (dose as per body weight and general condition) single dose. Post op regimen was tacrolimus in 95, cyclosporine in 5, mycophenolate in all and wysolone for 6 months in 96 of 100 pts. Post operatively in 26 patients creatinin levels normalized by day five allowing initiation of tacrolimus. In other 10 patients tacrolimus could be started only at day 10 with no ill effects or rejection episodes. In all patients CD 25 level was checked on day three and second dose of basiliximab given only if CD 25 more than 3%. Post op no patient had sustained neutropenia. Only two patients needed therapy for azotemia with postoperative dialysis. Two patients died of severe RF and sepsis. 15 patients has new onset diarrhea 99% in the first year after transplant of whom four were found to have CMV antigen positive – these resolved with IV gancyclovir in three with one patient who died of severe disseminated CMV infection 6 months after transplant. One had clostridium difficile positive diarrhoe – treated with IV vancomycin plus metronidazole. In seven patients diarrhoe resolved with termination of mycophenolate and other 4 had E-coli or Salmonella diarrhea resolved with oral antibiotics 20 patients all over the age of 40 had sustained tremors which resolved in 35 with beta blockers or neuro vitamins. Five had severe tremors which resolved after changing from tacrolimus to cyclosporine. 25 patients had severe headache treated with tricyclic antidepressants and five needs change to cyclosporine. 10 patients had episodes of leucopenia, eight of which resolved after temporary stoppage of vangancyclovir and reduced dose of mycophenolate. 2 pats need SC G-CSF. Conclusion: Overall mild side effects noted in 25 patients after heart transplant. Side effects like diarrhea, tremors and headache easily treated by clinical manipulation of drugs. One patient died of disseminated CMV infection, one from pneumonia and five of septic shock (first 15 days after transplant in three patients and three-six months in others).
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords